Is the Therapeutic Index Better with Gemcitabine-Based Chemoradiation

Ryan Smith, MD
University of Pennsylvania Cancer Center
Ultima Vez Modificado: 5 de noviembre del 2001

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Promise for Erlotinib + Cisplatin Chemoradiation in Cervical CA

Mar 11, 2014

Complete response for 94.4 percent of women with locally advanced cervical cancer

ASTRO: Long-Term Hormonal Tx No Better for Certain Prostate CA

Oct 4, 2013

No improvement in overall, disease-specific survival for men with intermediate-risk disease

New PCR-Based Assay Better Predicts Lung Cancer Survival

Jan 30, 2012

Assay identifies which early-stage NSCLC patients are at high risk of death after surgical resection